111 140

Cited 3 times in

Effects of Beraprost Sodium on Subjective Symptoms in Diabetic Patients with Peripheral Arterial Disease

 Hang Seob Yoon  ;  Woo Jin Choi  ;  Il Hoon Sung  ;  Ho Seong Lee  ;  Hyung Jin Chung  ;  Jin Woo Lee 
 Clinics in Orthopedic Surgery, Vol.5(2) : 145-151, 2013 
Journal Title
 Clinics in Orthopedic Surgery 
Issue Date
Adult ; Aged ; Aged, 80 and over ; Cohort Studies ; Diabetes Complications/drug therapy* ; Diabetes Complications/physiopathology ; Epoprostenol/analogs & derivatives* ; Epoprostenol/therapeutic use ; Female ; Humans ; Male ; Middle Aged ; Peripheral Arterial Disease/complications ; Peripheral Arterial Disease/drug therapy* ; Platelet Aggregation Inhibitors/therapeutic use* ; Prospective Studies ; Statistics, Nonparametric
Beraprost sodium ; Diabetes mellitus ; Intermittent claudication ; Peripheral arterial disease ; Prostaglandin I2
BACKGROUND: This study evaluated the effects of Beraprost sodium (Berasil) on subjective leg symptoms in patients with peripheral arterial disease caused by diabetes mellitus. METHODS: Ninety-four diabetic patients with peripheral arterial disease were treated with Beraprost in a fixed-dose, prospective, multicenter, cohort study. Beraprost (40 µg) was administered orally 3 times daily (120 µg/day) for 12 weeks. We developed a new disease-specific symptom questionnaire, which evaluated the effect of peripheral arterial disease on leg discomfort in daily life and assessed therapeutic responses to treatment. Patients were asked for their subjective assessment of symptoms on a written questionnaire before treatment and after 12 weeks of therapy. RESULTS: There was significant improvement in all estimated subjective symptoms (burning, coldness, edema, exertional pain, stabbing, and paresthesias) in the lower extremities at 12 weeks (p < 0.001). There were 18 patients with neuropathy in whom significant improvement was noted for 6 subjective symptoms at 12 weeks (p < 0.05). Adverse events considered to be drug-related were observed in 4 patients (4.3%), all of which were mild and resolved with discontinuation of the medication. CONCLUSIONS: Beraprost is effective as a treatment for improving various subjective symptoms in the lower extremities, such as burning, coldness, edema, exertional pain, stabbing, and paresthesias, in diabetic patients with peripheral arterial disease.
Files in This Item:
T201303568.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Orthopedic Surgery (정형외과학교실) > 1. Journal Papers
Yonsei Authors
Yoon, Hang Seob(윤항섭)
Lee, Jin Woo(이진우) ORCID logo https://orcid.org/0000-0002-0293-9017
Choi, Woo Jin(최우진)
사서에게 알리기


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.